Collegium Pharmaceutical (COLL) Non-Current Assets (2014 - 2026)

Collegium Pharmaceutical's Non-Current Assets history runs 13 years deep, the most recent figure standing at $906.3 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 17.9% year-over-year to $906.3 million; the TTM figure through Mar 2026 stood at $3.9 billion (down 2.76% YoY), while the FY2025 annual figure was $965.4 million, down 18.28% from the prior year.
• Non-Current Assets was $906.3 million for Q1 2026 at Collegium Pharmaceutical, down from $965.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.2 billion in Q3 2024 to a low of $543.2 million in Q2 2024.
• Historically, Non-Current Assets has averaged $847.7 million across 5 years, with a median of $835.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 152.32% in 2022, then dropped 19.72% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $754.1 million in 2022, then retreated by 19.68% to $605.7 million in 2023, then surged by 95.03% to $1.2 billion in 2024, then decreased by 18.28% to $965.4 million in 2025, then decreased by 6.13% to $906.3 million in 2026.
• The last three Non-Current Assets figures came in at $906.3 million (Q1 2026), $965.4 million (Q4 2025), and $993.5 million (Q3 2025), per Business Quant data.